BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15951154)

  • 1. Synchronous global assessment of gene and protein expression in colorectal cancer progression.
    Kwong KY; Bloom GC; Yang I; Boulware D; Coppola D; Haseman J; Chen E; McGrath A; Makusky AJ; Taylor J; Steiner S; Zhou J; Yeatman TJ; Quackenbush J
    Genomics; 2005 Aug; 86(2):142-58. PubMed ID: 15951154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential gene expression profiles and identification of the genes relevant to clinicopathologic factors in colorectal cancer selected by cDNA array method in combination with principal component analysis.
    Tsunoda T; Koh Y; Koizumi F; Tsukiyama S; Ueda H; Taguchi F; Yamaue H; Saijo N; Nishio K
    Int J Oncol; 2003 Jul; 23(1):49-59. PubMed ID: 12792775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptome profile of human colorectal adenomas.
    Sabates-Bellver J; Van der Flier LG; de Palo M; Cattaneo E; Maake C; Rehrauer H; Laczko E; Kurowski MA; Bujnicki JM; Menigatti M; Luz J; Ranalli TV; Gomes V; Pastorelli A; Faggiani R; Anti M; Jiricny J; Clevers H; Marra G
    Mol Cancer Res; 2007 Dec; 5(12):1263-75. PubMed ID: 18171984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gene expression profile represents the molecular nature of liver metastasis in colorectal cancer.
    Yamasaki M; Takemasa I; Komori T; Watanabe S; Sekimoto M; Doki Y; Matsubara K; Monden M
    Int J Oncol; 2007 Jan; 30(1):129-38. PubMed ID: 17143521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer.
    Lin YH; Friederichs J; Black MA; Mages J; Rosenberg R; Guilford PJ; Phillips V; Thompson-Fawcett M; Kasabov N; Toro T; Merrie AE; van Rij A; Yoon HS; McCall JL; Siewert JR; Holzmann B; Reeve AE
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):498-507. PubMed ID: 17255271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential CXC receptor expression in colorectal carcinomas.
    Rubie C; Kollmar O; Frick VO; Wagner M; Brittner B; Gräber S; Schilling MK
    Scand J Immunol; 2008 Dec; 68(6):635-44. PubMed ID: 18959627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of BMP7 in human colorectal cancer.
    Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
    Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiling in colorectal cancer using microarray technologies: results and perspectives.
    Nannini M; Pantaleo MA; Maleddu A; Astolfi A; Formica S; Biasco G
    Cancer Treat Rev; 2009 May; 35(3):201-9. PubMed ID: 19081199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of progressively overexpressed genes in tumorigenesis of colorectal cancers using cDNA microarray.
    Wang JY; Yeh CS; Tzou WS; Hsieh JS; Chen FM; Lu CY; Yu FJ; Cheng TL; Huang TJ; Lin SR
    Oncol Rep; 2005 Jul; 14(1):65-72. PubMed ID: 15944769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer.
    Talieri M; Mathioudaki K; Prezas P; Alexopoulou DK; Diamandis EP; Xynopoulos D; Ardavanis A; Arnogiannaki N; Scorilas A
    Thromb Haemost; 2009 Apr; 101(4):741-7. PubMed ID: 19350120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression of colorectal cancer: preoperative genetic diagnosis using endoscopic biopsies.
    Komori T; Takemasa I; Yamasaki M; Motoori M; Kato T; Kikkawa N; Kawaguchi N; Ikeda M; Yamamoto H; Sekimoto M; Matsubara K; Matsuura N; Monden M
    Int J Oncol; 2008 Feb; 32(2):367-75. PubMed ID: 18202759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer.
    Kim YH; Petko Z; Dzieciatkowski S; Lin L; Ghiassi M; Stain S; Chapman WC; Washington MK; Willis J; Markowitz SD; Grady WM
    Genes Chromosomes Cancer; 2006 Aug; 45(8):781-9. PubMed ID: 16708352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa.
    Bianchini M; Levy E; Zucchini C; Pinski V; Macagno C; De Sanctis P; Valvassori L; Carinci P; Mordoh J
    Int J Oncol; 2006 Jul; 29(1):83-94. PubMed ID: 16773188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
    Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Yamada R; Fujii S; Rino Y; Kunisaki C; Tanaka K; Masuda M; Imada T
    Oncol Rep; 2008 Aug; 20(2):359-64. PubMed ID: 18636198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global alterations in mRNA polysomal recruitment in a cell model of colorectal cancer progression to metastasis.
    Provenzani A; Fronza R; Loreni F; Pascale A; Amadio M; Quattrone A
    Carcinogenesis; 2006 Jul; 27(7):1323-33. PubMed ID: 16531451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic mRNA expression patterns of inflamed, benign, and malignant colorectal biopsy specimen and their correlation with peripheral blood results.
    Galamb O; Sipos F; Solymosi N; Spisák S; Krenács T; Tóth K; Tulassay Z; Molnár B
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2835-45. PubMed ID: 18843029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression.
    Carvalho B; Postma C; Mongera S; Hopmans E; Diskin S; van de Wiel MA; van Criekinge W; Thas O; Matthäi A; Cuesta MA; Terhaar Sive Droste JS; Craanen M; Schröck E; Ylstra B; Meijer GA
    Gut; 2009 Jan; 58(1):79-89. PubMed ID: 18829976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BAG-1 is up-regulated in colorectal tumour progression and promotes colorectal tumour cell survival through increased NF-kappaB activity.
    Clemo NK; Collard TJ; Southern SL; Edwards KD; Moorghen M; Packham G; Hague A; Paraskeva C; Williams AC
    Carcinogenesis; 2008 Apr; 29(4):849-57. PubMed ID: 18204076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.